Breast cancer is the most common form of cancer in women, and the numbers of diagnoses continue to increase annually. Thanks to medical advances over the past 30 years, many women are facing a more positive outlook, but only if it’s detected early. For women who are in advanced stages of breast cancer, whose tumors express markers of poor outcome, or are suffering from a recurrence of the disease, more effective therapies are needed to give them a better chance of survival.
In this webinar we discuss recent advances in treatments that have contributed to improving the chances of surviving breast cancer, and what is being done to develop new therapies targeting women that are resistant to standard therapy or are at a high risk of relapse. This webinar is designed to help researchers choose the right model, for the right tumor subtype, to ensure the most effective treatments translate to the clinic.
Elizabeth Anderson, PhD
Scientific Director, Oncology
We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.